Industry News

Biotech firm can combat EMS, SRS, others with phage technology

DATE: 10th October 2017

By using naturally occurring ‘phages’, company can challenge nearly any bacterial disease impacting the aquaculture industry.

Biotechnology company Fixed Phage has developed a way to tackle prevalent diseases in the aquaculture industry, including Early Mortality Syndrome (EMS) in shrimp and Salmon Rickettsial Syndrome (SRS), its commercial director Athol Haas, told IntraFish.

Read Full Article here:
www.intrafish.com

Related Articles

Antibiotic resistance develops when bacteria become less sensitive to antibiotics, rendering them less effective or...
DATE: 29th May 2023

Antibiotic resistance develops when bacteria become less sensitive to antibiotics, rendering them less effective or ineffective at killing bacteria and treating infections. We urgently need new therapeutic strategies to combat...

  Innovative UK phage biotechnology company, Fixed Phage, has appointed Dr Neil Clelland as its...
DATE: 26th May 2023

  Innovative UK phage biotechnology company, Fixed Phage, has appointed Dr Neil Clelland as its new Chief Executive Officer (CEO). The company has also announced its new Chief Operations Officer...

Bacteriophages are viruses that specifically target and destroy pathogenic bacteria, making them a promising research...
DATE: 17th May 2023

Bacteriophages are viruses that specifically target and destroy pathogenic bacteria, making them a promising research topic with significant implications for human health and the environment. Bacteriophage-based solutions can be applied...